Back to News
Market Impact: 0.6

British American Tobacco stock initiated with Buy rating at Jefferies

BTIRAI
Company FundamentalsAnalyst InsightsAnalyst EstimatesCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)M&A & RestructuringCorporate Earnings
British American Tobacco stock initiated with Buy rating at Jefferies

British American Tobacco (BTI) is drawing significant institutional attention, with Jefferies initiating a Buy rating and a GBP48.00 price target, citing the company's improving traditional combustibles business, strong smoke-free product potential, and a 35% valuation discount relative to the wider tobacco sector. BTI recently completed a $1.42 billion sale of its ITC stake, exceeding expectations, and expanded its share buyback program to £1.1 billion, signaling robust capital returns. Despite some underperformance in its vapor segment, the company reported improved U.S. combustibles and strong VELO growth, with management projecting mid-single-digit full-year revenue growth, reinforcing positive outlooks from Deutsche Bank and BofA Securities.

Analysis

British American Tobacco (BTI) is receiving strong bullish signals from the analyst community, led by a new 'Buy' rating and a GBP48.00 price target from Jefferies, which identifies the company as its top sector pick. This positive outlook is predicated on improving profitability in the core combustibles business, a strengthening balance sheet, and significant potential in smoke-free products. A key valuation argument is the stock's current 35% discount to the wider tobacco sector, a gap Jefferies expects to narrow. This sentiment is echoed by Deutsche Bank and BofA Securities, which have also recently issued 'Buy' ratings with price targets of £38.00 and £39.00 respectively. Management's strategy appears to reinforce this confidence, demonstrated by the recent $1.42 billion sale of its ITC stake and the subsequent expansion of its share buyback program to £1.1 billion, signaling a robust commitment to capital returns. Operationally, the company's latest trading update presented a mixed picture; while U.S. combustibles and the VELO oral product showed improvement, the vapor segment underperformed. Despite this setback, management has reaffirmed its full-year guidance for mid-single-digit revenue growth, suggesting confidence in the overall business trajectory.

AllMind AI Terminal